Physician profile
John T Williams
NPI 1437184306
$16,080.93
in general payments reported to CMS, 2019-2025
38 companies · $1,607 in 2025
The $1,607 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,209 · 2020: $1,274 · 2021: $2,470 · 2022: $1,354 · 2023: $2,644 · 2024: $523 · 2025: $1,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,568 · Travel and Lodging: $2,172 · Education: $35.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,567.82 |
| Travel and Lodging | $2,171.50 |
| Education | $35.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,250.03 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $4,427.59 | 2019-2025 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Abbvie INC. | $1,228.27 | 2022-2023 | Strattice Reconstructive Tissue Matrix Bps, Natrelle Saline-Filled Breast Implants |
| Tela Bio, INC. | $408.12 | 2020-2021 | |
| Kerecis Limited | $359.60 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Allergan, INC. | $344.07 | 2019-2022 | |
| Davol INC. | $246.94 | 2019-2025 | Arista |
| Mimedx Group, INC. | $245.86 | 2024-2025 | |
| Smith+Nephew, INC. | $232.50 | 2019-2020 | |
| Medtronic, INC. | $193.11 | 2023-2025 | Endoflip, Aquamantys(Tm), Plasmablade(Tm) |
| Stryker Corporation | $164.73 | 2022 | |
| Edwards Lifesciences Corporation | $117.45 | 2019 | |
| Csl Behring | $107.13 | 2019-2022 | |
| Ethicon US, LLC | $102.84 | 2019-2022 | |
| Covidien LP | $97.30 | 2019 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.